{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T11:48:10Z","timestamp":1794311290766,"version":"4.9.0"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2020,1,28]]},"abstract":"<jats:p>\n                    <jats:named-content content-type=\"genus-species\">Stenotrophomonas maltophilia<\/jats:named-content>\n                    is difficult to treat due to the production of multiple intrinsic and acquired mechanisms of resistance. Trimethoprim-sulfamethoxazole (TMP-SMZ) and the fluoroquinolones have traditionally been considered the drugs of choice but are plagued by increasing resistance and adverse drug effects. The objective of this study was to evaluate the\n                    <jats:italic>in vitro<\/jats:italic>\n                    activities of 12 clinically relevant antimicrobials against clinical\n                    <jats:named-content content-type=\"genus-species\">S. maltophilia<\/jats:named-content>\n                    isolates nonsusceptible to levofloxacin and\/or TMP-SMZ.\n                  <\/jats:p>","DOI":"10.1128\/jcm.01603-19","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T08:40:01Z","timestamp":1574066401000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":59,"title":["Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and\/or Trimethoprim-Sulfamethoxazole"],"prefix":"10.1128","volume":"58","author":[{"given":"M.","family":"Biagi","sequence":"first","affiliation":[{"name":"College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Tan","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jurkovic","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vialichka","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Meyer","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. E.","family":"Mendes","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-8400","authenticated-orcid":false,"given":"E.","family":"Wenzler","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy210.1024"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.09.84"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-009-0709-5"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.12.006"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02276"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/320183"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01774-09"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0279-3"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1304.061378"},{"key":"e_1_3_2_11_2","first-page":"359","article-title":"Stenotrophomonas maltophilia bacteremia in adults: four years\u2019 experience in a medical center in northern Taiwan","volume":"37","author":"Wang WS","year":"2004","unstructured":"Wang WS, Liu CP, Lee CM, Huang FY. 2004. Stenotrophomonas maltophilia bacteremia in adults: four years\u2019 experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 37:359\u2013365.","journal-title":"J Microbiol Immunol Infect"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01682-13"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv456"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01191"},{"key":"e_1_3_2_15_2","article-title":"Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot","volume":"6","author":"Gajdacs M","year":"2019","unstructured":"Gajdacs M, Urban E. 2019. Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Health Serv Res Manag Epidemiol 6:2333392819870774.","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01324-13"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.09.015"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.03.019"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00788-19"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy210.2072"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01154-19"},{"key":"e_1_3_2_22_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2019","unstructured":"CLSI. 2019. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S29. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_23_2","unstructured":"Cai B Echols R Morgan G Marcella S Ariyasu M Sawada T Nagata T. 2019. Prevalence and treatment of Stenotrophomonas maltophilia among adult patients in United States hospitals between 2010 and 2015 poster 0911. Abstr 29th Eur Clin Conf Microbiol Infect Dis."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr242"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01288-13"},{"key":"e_1_3_2_26_2","unstructured":"Morrissey I Bassetti M Magnet S Hawser S Olesky M Fyfe C. 2017. In vitro activity of eravacycline and comparator agents against Acinetobacter baumannii Stenotrophomonas maltophilia and Enterobacteriaceae including carbapenem-resistant and ESBL phenotype subgroups collected from European hospitals in 2015 poster P1260. 27th Eur Congr Clin Microbiol Infect Dis Vienna Austria."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Bassetti M Corey R Doi Y Morrissey I Grossman T Olesky M Sutcliffe J. 2016. In vitro global surveillance of eravacycline and comparators against Enterobacteriaceae Acinetobacter baumannii Stenotrophomonas maltophilia including multidrug-resistant (MDR) isolates over a three-year period (2013\u201315) poster 1825. ID Week 2016 26 to 30 October 2016 New Orleans LA.","DOI":"10.1093\/ofid\/ofw172.1373"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00018-17"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02327-17"},{"key":"e_1_3_2_30_2","volume-title":"27th Eur Congr Clin Microbiol Infect Dis","author":"Huband M","year":"2017","unstructured":"Huband M, Rhomberg P, Sader H, Schuchert J, Flamm R. 2017. In vitro activity of omadacycline and comparators against Gram-negative bacterial isolates collected from patients in European medical centres (2016): results from the SENTRY antimicrobial surveillance program, poster P1253. 27th Eur Congr Clin Microbiol Infect Dis, 22 to 25 April 2017, Vienna, Austria."},{"key":"e_1_3_2_31_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"CLSI","year":"2012","unstructured":"CLSI. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00893"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.11.008"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00549"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/23744235.2015.1064542"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2012.53.2.439"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156690"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00574-09"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","unstructured":"Shortridge D Arends SJR Streit JM Castanheira M Flamm RK. 2019. Minocycline activity against Stenotrophomonas maltophilia isolates from patients in US hospitals poster 1584. ID Week 2019 Washington DC 2 to 6 October 2019.","DOI":"10.1093\/ofid\/ofz360.1448"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01603-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01603-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T05:39:57Z","timestamp":1646458797000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.01603-19"}},"subtitle":[],"editor":[{"given":"Nathan A.","family":"Ledeboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,28]]}},"alternative-id":["10.1128\/JCM.01603-19"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01603-19","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"2019-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01603-19"}}